Harnessing complement biomarkers for precision cancer care. Houcine Hamidi
Semin Immunol. 2025 May 15;78:101963. doi: 10.1016/j.smim.2025.101963. Online ahead of print. ABSTRACT The tumor microenvironment (TME) consists of various immune and non-immune cells, along with proteins from different origins, and plays a crucial role in tumor development, treatment response, and patient prognosis. Complement system is a key player in the TME. It is a proteolytic … Read more